Vilon is a two-amino-acid peptide promoted as an immune and longevity bioregulator. The searchable literature is mostly experimental and review-level material, not the independent, controlled human evidence needed to validate wellness dosing claims.
Reviewed by the PepGuard team · Last reviewed Jul 28, 2026
Synthetic dipeptide (lysine-glutamic acid) · also sold as Lys-Glu, lysyl-glutamic acid
Vilon is a defined dipeptide, also indexed as lysyl-glutamic acid. That is useful for searching the literature, but it does not make the immune, longevity, or "bioregulator" claims clinically established.
The available record is not a modern, independently replicated program with a defined patient population, dose, comparator, and prespecified clinical outcome. Without that, a course schedule is marketing detail, not a medical finding.
| What's cited | Range |
|---|---|
| Established human clinical dose | None |
No controlled human dose-ranging study was identified that supports the online Vilon protocols. The absence of a chart here is intentional: a vendor's capsule or injection schedule is not clinical evidence.
| Signal | Frequency | Context |
|---|---|---|
| Human adverse-event profile | unknown / not studied | No adequate controlled human safety dataset was identified for the marketed wellness uses. |
| Product purity, sterility, and dose accuracy | unknown / not studied | Published experimental papers do not verify a commercial product's contents. |
Check the research before treating a protocol as established.